chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse, via a company representative, concerning a female patient (age not reported), who in November 2007, was vaccinated with a dose, 0.5 ml, of Gardasil (lot # not reported). In December 2007, one month after vaccination, the patient developed shingles. At the time of this report, the outcome of the event was unknown. Additional information has been requested.
patient recieved a Monovalent Vaccine instead of Bivalent after 9/1
fever 101; moderate headache; tachycardia at rest; This is a spontaneous report from a contactable nurse reporting for herself. A 40-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EL1287, expiry date: not reported), via an unspecified route of administration, on 12Jan2021 04:15 PM at a single dose on the left arm for COVID-19 immunization. The patient was not pregnant. She received the vaccine at a workplace clinic. She had not received any other vaccines in four weeks. Medical history included arthritis. The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL), multivitamin, and airborne immune supplement; these are the other medications she took in two weeks. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EL1284, expiry date: not reported), via an unspecified route of administration, on 23Dec2020 04:45 PM at a single dose on the left arm for COVID-19 immunization. On 13Jan2021 03:00 AM, within 12 hours of 2nd vaccine dose, the patient experienced fever 101, moderate headache, tachycardia at rest. The patient was not diagnosed with COVID prior to vaccination and had not tested for COVID post vaccination. The patient received no treatment for the reported adverse events. Outcome of the events was recovering.
On 03/29/2021 I ended up with Autoimmune Hemolytic Anemia. It was found at a doctor's appointment. My doctor said they believed it was caused by the vaccine. They sent me to the hospital that day. I had to get 2 blood transfusions and spend 10 days in the hospital starting 03/29/2021. I have had a lot of blood work over the past few months. I have had to take medicines including Prednisone a couple times. It is a very hard to get rid of this disease once you have it.
Day 1 thru 4 I could not lift my arm.  Day 5 thru 9 arm is still but better. Still not able to move arm in certain positions Day 10 thru 11 the pain is getting worse. difficult to life my arm.  All 11 days the pain wakes me up at when I try to move because.  No redness, no swelling. Nothing is visible.  Pain is near the top of my shoulder next to my armpit.
sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (sore arm) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a non-contactable consumer. A 71-year-old female patient (reporter's mother) received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose via an unknown route on 04Mar2021 for Covid-19 immunization. Medical history and concomitant drug were not provided. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient contracted COVID a few days before her second dose (event onset date 22Mar2021). She felt symptoms about 3 days before she was scheduled to receive her second dose. Covid test on 23Mar2021 was positive. She was officially diagnosed with COVID on 25Mar2021, the day of her scheduled second dose, which she did not get. She died several days later. The adverse event result in doctor or other healthcare professional office/clinic visit. Treatment received for the event. The patient died on an unknown date with death cause of COVID.  It was unknown if autopsy performed.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test
COLD; PAIN; DIARRHEA; RASH; HEADACHE; FEVER; NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced cold, pain, diarrhea, rash, headache, fever, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cold, pain, headache, fever, nausea, diarrhea and rash was not reported. This report was non-serious.
Fever or Chills  Cough  Fatigue  Muscle or body aches  Sore throat  Congestion or running nose
Administered vaccination on Thursday August 5th at approximately 11 am.  Woke up Friday morning with a yeast infection and a stye in my left eye.  The Employee Health Dept administered it because they recommended the Hepititis B Vaccination - I don't which one specifically there is a whole list below.
30 hours after vaccine administration (1st dose), sudden onset of severe, shooting nerve pain in arms, legs, and ribs (9 out of 10). Within minutes, severe skin burning (like severe sunburn) developed on the entire skin. Then moderate  headache developed. All symptoms experienced previously during COVID infection in March-April 2020, but were less severe as during COVID the symptoms were cycling, while now the symptoms were sustained. Tylenol reduced nerve/muscle pain and headeacha some, but nothing helped with skin burn.  Mild skin burning and waves of mild nerve pain persisted the following 2 days.
Headache Sore arm Low grade temp - 99.7 Lethargic Stuffy head, nose and ears
At 48 hours After vaccines I developed a headache nauseous Hot the following day I was sore all over still having a headache still nauseous my ribs hurt my hand hurt four days today still not well tired weak headache! So sick ! I do not wish to have the second dose! I really thought I was gonna die
Rt arm red, raised, erythemic hive, mild itching. She used Hydrocortisone/BENADRYL Cream on it. DTAP was given 1-28-10 and came back on 2-4-10. Noticed a red knot at injection sight the day after it was given.
Hives and swelling, starting on hip bone. Rash then continued to spread across abdomen and down legs (mostly on right side of body).
Very painful injection site; overall fatigue; muscle cramps in my legs; This is a spontaneous report from a contactable healthcare professional.  A 50-year-old female patient started received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EH9899), intramuscular into the left arm on 16Dec2020 at 18:30 as single dose for COVID-19 immunization. Medical history included chronic bronchitis, asthma and hypertension from an unknown date.  Concomitant medication included losartan (MANUFACTURER UNKNOWN).  No allergies to medications, food, or other products were reported. The patient experienced very painful injection site, overall fatigue and " muscle cramps in my legs " on 17Dec2020, at 12:00. The events were not serious, and no treatment was required.  The outcome of very painful injection site, overall fatigue and " muscle cramps in my legs " was recovering.
Redness, itching, swelling, heat at injection site 1 week after vaccine. It has been about 24 hours. Mild symptoms.
Pt started vomiting and developed tightness in chest. 1040 - BP 138/84 temp 98.2 pulse 80, hives on neck & chest 1041 - BP 170/90, pulse 84, resp. 24 50 mg BENADRYL PO given 1044 BP 152/98 pulse 72 1050: BP 148/108, pulse 80 to ER via EMS.
This spontaneous report as received from an office manager refers to a patient of unknown age. On 21-AUG-2012 the patient was vaccinated with a dose of ZOSTAVAX (lot # 671780/0170AE, exp. date 13-JUN-2013). It was reported that the diluent for ZOSTAVAX was frozen inadvertently was used to reconstitute ZOSTAVAX. The reporter could not provide temperature reading of the freezer in which diluents were kept and stability of diluents could not be determined. It was unknown if the patient sought medical attention or not. No adverse effect reported. Additional information has been requested.
08/29/22 presents to EC ED for "altered mental status". PMHx of "type 2 diabetes, coronary artery disease, stage II as of CKD"
Daughter started getting itchy patches of hives. We treated the hives with topical hydrocortisone and giving Benadryl. The hives went away but then can back the following day. Hives covered a huge portion of her body and we gave her more Benadryl and took her to the hospital.   After going over symptoms and history of the past two days the doctor believes the periodic hive breakouts are a reaction to the covid vaccine.
Around 6 PM Same day felt dizzy and checked my blood pressure and read sys 208/ dia  104/ pulse 105 . Rested called doctor and he prescribed Amlodipine besylate 5 mg tab.blood pressure stood high until 8 pm. So from 6 pm to 8 pm uncomfortable and high average 181/101/108 . At 8 pm blood pressure read 153/98/92 and that?s when I took 1 pill from doctor prescribed. Over evening and night had body temperature around 37.2-37.5 C. Feeling low fever. Morning at 7 am things improved blood pressure is 138/91/92 still had low fever 37.2C. Reporting currently my status to my doctor. Consultation with doctor was over the phone.
Pfizer vaccine was administered outside of our facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------- R57.0 CARDIOGENIC SHOCK 8/8/2021 ATRIAL FIBRILLATION, PAROXYSMAL R57.0 CARDIOGENIC SHOCK 8/8/2021 SYSTOLIC HEART FAILURE, STAGE D, UNSPECIFIED ACUITY R57.0 CARDIOGENIC SHOCK 8/8/2021 CHF EXACERBATION, UNSPECIFIED R57.0 CARDIOGENIC SHOCK 8/8/2021 SYSTOLIC HEART FAILURE, ACUTE ON CHRONIC R57.0 CARDIOGENIC SHOCK 8/8/2021 ASTHMA, UNSPECIFIED R57.0 CARDIOGENIC SHOCK 8/8/2021 SYSTOLIC HEART FAILURE, ACUTE ON CHRONIC R57.0 CARDIOGENIC SHOCK 8/8/2021 VENTRICULAR TACHYCARDIA, UNSPECIFIED TYPE R57.0 CARDIOGENIC SHOCK 8/8/2021 VENTRICULAR TACHYCARDIA, UNSPECIFIED TYPE R57.0 CARDIOGENIC SHOCK 8/8/2021 VENTRICULAR TACHYCARDIA, UNSPECIFIED TYPE R57.0 CARDIOGENIC SHOCK 8/8/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R57.0 CARDIOGENIC SHOCK 8/8/2021 ACUTE CHOLECYSTITIS    ATRIAL FIBRILLATION, PAROXYSMAL
The patient was admitted to hospital 2 days after vaccination with diagnosis of cellulitis.; This spontaneous report was received from a physician via company representative, referring to a 15 year old patient human immunodeficiency virus (HIV) positive. The patient's medical history, concomitant medications, and historical drugs were not reported.  On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) via intramuscular route (strength, dose, frequency, anatomical location,lot # and expiration date were unknown), and with  meningococcal b rfhbp rnada rnhba omv vaccine (e. coli)(BEXSERO) (strength, route, dose, frequency, anatomical location, indication, lot # and expiration date were unknown) at same time in same deltoid for vaccination.   On an unknown date (reported as "2 days after vaccination"), the patient seek for medical attention and was admitted to hospital with diagnosis of cellulitis, and received treatment for the event.  At the time of the report, it was reported that the vaccination was discontinued, and the outcome of cellulitis was reported as resolving. The patient was discharged and was doing fine at home.    Upon internal review, cellulitis was determined to be a medically significant event.
RECURRENCE OF FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a female of unspecified age, race and ethic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On 08-MAR-2021, the patient previously received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN), 1 in total, dose was not reported, for prophylactic vaccination (Dose series in number 1).  On MAR-2021, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced flu like symptoms. (Dose series in number 1). The patient recovered from flu like symptoms on an unspecified date. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211D21A, expiry: UNKNOWN) dose was not reported, 1 total administered on 02-DEC-2021 for prophylactic vaccination (Dose series in number 2). No concomitant medications were reported.  On an unspecified date in DEC-2021, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced recurrence of flu like symptoms (Dose series in number 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from recurrence of flu like symptoms on an unspecified date in DEC-2021. This report was non-serious. This case, involving the same patient is linked to 20211237910 (Dose series in number 1).
3 hrs after vaccine bad headache H/A for 2 hrs. For next 2 days milder H/A and flu symptoms and nausea (some).
Patient seen on 5/22/2007 with redness and tenderness to Right thigh.
Eight days after the first dose of the vaccine I had a raised white welt on my arm. The next day it was raised red , hot and itchy. It grew every day, and it was worse in the evening. At it's largest it was 3-4 inches and the center was at the injection site but it wasn't a perfect circle. I got the second dose in the other arm and I did not have any problem with my arm.
Swollen lymph node above my left clavicle, tender and warm. First felt when I woke up around 8:00 AM on 1/17/21.
Information has been received from a physician's assistant (PA) concerning an 80 year old male with a history of lymphoma and chemotherapy who had close contact with a child who was vaccinated with a dose of VARIVAX. The PA reported that the patient subsequently developed a systemic itchy, vesicular rash. Unspecified medical attention was sought the patient was subsequently hospitalized for one week. A skin biopsy was done with a diagnosis of drug reaction. At the time of this report, the patient's systemic itchy vesicular rash persisted. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it present to identify if it is associated with the wild-type (WT) VZV strain or with the manufacturer vaccine reported VZV strain. Additional information has been requested.
The pt reports that he received HepB #1 vaccine on 18 April 2014, about 20-30 mins following vaccination he was walking in hospital and started feeling "out of body" but was still walking and communicating. He got home and this feeling transitioned into a headache. He says the headache was intense for 3 days and slowly tapered off for several days. He also reports that during the time he started feeling increased irritability, anger, decreased concentration and decreased emotion/caring/libido. These feeling lasted for 3-4 weeks. He reports he is back to his baseline.
I received the vaccination on April 25th at 2:15pm. I waited at the facility until 2:30pm to be sure I didn't have any immediate side effects or allergic reactions. Upon arriving home around 3:00pm, I noticed the injection sight had become itchy. I then noticed later in the day that my arm was beginning to hurt and the pain progressively got worse. By the end of the day, I was unable to move my arm much without any pain.  The next morning (April 26th), the injection sight was swollen upon physical examination but was not noticably swollen. I did not check the sight through the day but noticed at the end of the day when getting ready for bed (around 9:00pm) that the injection sight was swollen, itchy, red, and extremely sensitive to touch.   Today, April 27th, the sight is still red, sensitive, and swollen but the pain level in relation to moving my arm has decreased dramatically throughout the day and I am able to move with little to no pain.
swelling inflammation of extremeties, severe pain, headache, boneaches, weakness, edema,
8/12/21 Induration 3 inches by 3inches, pain, redness, swelling upon awakening, by 8pm I had chills n fever. On 8/13/21 I continued with all of the above plus, nausea, diarrhea, weakness, body aches. I felt like I was getting COVID all over again. I was Positive for COVID 6/2020 and was still donating convalecent plasma until July 2021, I stop donating because my vein was disappearing. I still had antibodies to  COVID
Bottom lip began to tingle and then the tip of the tongue did that, then that continued to half of my tongue; Bottom lip began to go numb, then the tip of the tongue did that, then that continued to half of my tongue; This is a spontaneous report received from a non-contactable reporter (Consumer). The reporter is the patient.  A female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Severe Allergies" (unspecified if ongoing); "Ragweed allergy" (unspecified if ongoing); "Food allergy" (unspecified if ongoing), notes: Allergies: Egg whites, Corn, Oats, Cinnamon, Safflower; "NSAID Allergy" (unspecified if ongoing). Concomitant medications included: FLONASE [FLUTICASONE PROPIONATE]; CLARITIN-D; MUCINEX; PREDNISONE. Past drug history included: Aspirin, reaction: "Drug allergy". The following information was reported: PARAESTHESIA ORAL (non-serious) with onset 07Mar2021, outcome "recovered" (Mar2021), described as "Bottom lip began to tingle and then the tip of the tongue did that, then that continued to half of my tongue"; HYPOAESTHESIA ORAL (non-serious) with onset 07Mar2021, outcome "recovered" (Mar2021), described as "Bottom lip began to go numb, then the tip of the tongue did that, then that continued to half of my tongue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of paraesthesia oral, hypoaesthesia oral.  Additional Information: On 07Mar2021, the patient experienced that her bottom lip began to tingle and go numb, then the tip of the tongue did that, then that continued to half of her tongue. She immediately took diphenhydramine (BENADRYL) and famotidine (PEPCID) then once got home, she added prednisone. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient took other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 via nasal swab and the result found to be negative   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021351524 Same patient and drug; Different dose and event
Tested positive for COVID-19 21Apr2021; Tested positive for COVID-19 21Apr2021; This is a spontaneous report from a contactable consumer. A 46-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 2 via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 (Batch/Lot Number: EN6203) as SINGLE DOSE for covid-19 immunisation.  Medical history included prior cancer (nonspecific) from an unknown date and unknown if ongoing. Patient was not pregnant. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 at 03:00PM on 24Feb2021, Lot EL3247 for covid-19 immunization.  Concomitant medication(s) included ascorbic acid, bioflavonoids nos, hesperidin, malpighia glabra, rosa canina, rutoside (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]) taken for an unspecified indication, start and stop date were not reported.  The patient received Dose 2 on 17Mar2021 then had fever 16Apr that resolved in 2 days. Three days later she experienced loss of smell. Patient was tested positive for COVID-19 21Apr2021. Outcome for events vaccination failurewas unknown , 21apr2021. Outcome for tested positive for covid-19, fever , loss of smell was recovering.  The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): positive on 21Apr2021.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: Unknown. The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation; CoviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "vaccinated and boosted, but still caught Covid earlier this year". Therapeutic measures were taken as a result of Covid-19, drug ineffective with Paxlovid. Clinical course: The patient was vaccinated and boosted, but still caught Covid earlier this year. The patient was prescribed Paxlovid and now the patient had rebounded twice. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 05-MAR-2023 This case was reported by a patient via interactive digital media. The patient had shingles twice even one time he/she had the Shingles shot. The physician told to the patient that, he/she would still have the shingles but with the shot, they were not as severe. The follow-up could not be possible as no contact details were available.
Presented at 8:20P with hives and severe itching on head, torso, arms.
Erythema, itch, discomfort with palpation , swelling and firmness felt under the skin at injection site. Area approximately quarter size.